Newly Approved Drug Therapies (262): Trazadone 150mg, Teva Pharmaceutical

Description of Medical Areas

About the FDA Approved Listings

Drugs Approved by the FDA

Drug Name: Trazadone 150mg

The following information is obtained from various newswires, published medical journal articles, and medical conference presentations.

Company: Teva Pharmaceutical
Approval Status: Approved May 1997
Treatment for: depression

General Information

Trazadone 150mg tablets have been approved to manufacture and market as a treatment for depression. Teva previously received approval for 50mg and 100mg dosage strengths. Trazadone is the generic equivalent of Bristol Meyers Squibb’s Desyrel 7.

Back to Drug Listing

Drug listing last updated on June 20, 2008

Patient Resources: [ Trial Listing ] [ Notification Services ] [ Drug Directories ]
[ About Clinical Research ] [ Patient Resources ] [ Patient Bookstore ]
Professional Resources: [ Research Center Profiles ] [ Industry Provider Profiles ] [ Jobs in Clinical Research ]
[ Industry News ] [ Professional Resources ] [ Professional Bookstore ]
General: [ Search ] [ Site Map ] [ Your Privacy ] [ CW World ] [ Home ]